{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:40:09Z","timestamp":1793907609684,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10147-021-01953-5","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:02:49Z","timestamp":1623409369000},"page":"1767-1774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40\u00a0years or younger"],"prefix":"10.1007","volume":"26","author":[{"given":"Takeshi","family":"Makabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-6057","authenticated-orcid":false,"given":"Wataru","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Miyabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwamu","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmg.2007.048991","volume":"44","author":"HF Vasen","year":"2007","unstructured":"Vasen HF, Moslein G, Alonso A et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary no-polyposis cancer). J Med Genet 44:353\u2013362","journal-title":"J Med Genet"},{"key":"1953_CR2","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1001\/jama.293.16.1986","volume":"293","author":"V Pinol","year":"2005","unstructured":"Pinol V, Gastells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986\u20131994","journal-title":"JAMA"},{"key":"1953_CR3","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","volume":"66","author":"H Hampel","year":"2006","unstructured":"Hampel H, Frankel W, Panescu J et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810\u20137817","journal-title":"Cancer Res"},{"key":"1953_CR4","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1002\/cncr.28933","volume":"120","author":"SE Ferguson","year":"2014","unstructured":"Ferguson SE, Aronson M, Pollett A et al (2014) Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer 120:3932\u20133939","journal-title":"Cancer"},{"key":"1953_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2013.51.2129","volume":"32","author":"DD Buchanan","year":"2014","unstructured":"Buchanan DD, Tan YY, Walsh MD et al (2014) Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol 32:90\u2013100","journal-title":"J Clin Oncol"},{"key":"1953_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/PAS.0000000000000544","volume":"40","author":"AM Mills","year":"2016","unstructured":"Mills AM, Sloan EA, Thomas M et al (2016) Clinicopathological comparison of Lynch syndrome-associated and \u201cLynch-like\u201d endometrial carcinomas identified on universal screening using mismatch repair protein immunohistochemistry. AM J Surg Pathol 40:155\u2013165","journal-title":"AM J Surg Pathol"},{"key":"1953_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.humpath.2015.06.022","volume":"46","author":"J Mas-Moya","year":"2015","unstructured":"Mas-Moya J, Dudley RE, Brand RE et al (2015) Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. Hum Pathol 46:1616\u20131625","journal-title":"Hum Pathol"},{"key":"1953_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/PGP.0000000000000312","volume":"36","author":"JC Watkins","year":"2017","unstructured":"Watkins JC, Yang EJ, Muto MG et al (2017) Universal screening for mismatch-repair deficiency in endometrial cancers to identify patients with Lynch syndrome and Lynch-like syndrome. Int J Gynecol Pathol 36:115\u2013127","journal-title":"Int J Gynecol Pathol"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarino","year":"1999","unstructured":"Aarino M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214\u2013218","journal-title":"Int J Cancer"},{"key":"1953_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","volume":"137","author":"E Stoffel","year":"2009","unstructured":"Stoffel E, Mukherjee B, Raymond VM et al (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621\u20131627","journal-title":"Gastroenterology"},{"key":"1953_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249","journal-title":"Nat Methods"},{"key":"1953_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jjco\/hyx019","volume":"47","author":"K Masuda","year":"2017","unstructured":"Masuda K, Hirasawa A, Irie-Kunitomi H et al (2017) Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer. Jpn J Clin Oncol 47:401\u2013406","journal-title":"Jpn J Clin Oncol"},{"key":"1953_CR13","first-page":"217","volume-title":"World Health Organization classification of tumours: pathology and genetics\u2014tumours of the breast and female genital organs","author":"SG Silverberg","year":"2003","unstructured":"Silverberg SG, Mutter GL, Kurman JR et al (2003) Epithelial tumours and related lesions. In: Tavassoli FA, Devilee P (eds) World Health Organization classification of tumours: pathology and genetics\u2014tumours of the breast and female genital organs. IARC Press, Lyon, pp 217\u2013232"},{"key":"1953_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103\u2013104","journal-title":"Int J Gynaecol Obstet"},{"key":"1953_CR15","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.3802\/jgo.2018.29.e21","volume":"29","author":"W Yamagami","year":"2018","unstructured":"Yamagami W, Susumu N, Makabe T et al (2018) Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility? J Gyencol Oncol 29:e21","journal-title":"J Gyencol Oncol"},{"key":"1953_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","volume":"14","author":"O Inoue","year":"2016","unstructured":"Inoue O, Hamatani T, Susumu N et al (2016) Factors affecting pregnancy outcomes in young women treated with fertility- preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol 14:2","journal-title":"Reprod Biol Endocrinol"},{"key":"1953_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1953_CR18","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bonaiti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304\u20132310","journal-title":"JAMA"},{"key":"1953_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/modpathol.2012.30","volume":"25","author":"C Huth","year":"2012","unstructured":"Huth C, Kloor M, Voigt AY et al (2012) The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Mod Pathol 25:911\u2013916","journal-title":"Mod Pathol"},{"key":"1953_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/djp473","volume":"102","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193\u2013201","journal-title":"J Natl Cancer Inst"},{"key":"1953_CR21","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","volume":"3","author":"N Ryan","year":"2017","unstructured":"Ryan N, Morris J, Green K et al (2017) Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol 3:1702\u20131706","journal-title":"JAMA Oncol"},{"key":"1953_CR22","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","volume":"30","author":"C Engel","year":"2012","unstructured":"Engel C, Loeffler M, Steinke V et al (2012) Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:4409\u20134415","journal-title":"J Clin Oncol"},{"key":"1953_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell ML, Brady MF et al (2016) Inherited mutations in women with ovarian carcinoma. Jama Oncol 2:482\u2013490","journal-title":"Jama Oncol"},{"key":"1953_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/PAP.0b013e31825c6b76","volume":"19","author":"BA Clarke","year":"2012","unstructured":"Clarke BA, Cooper K (2012) Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas. Adv Anat Pathol 19:231\u2013238","journal-title":"Adv Anat Pathol"},{"key":"1953_CR25","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/j.1349-7006.2008.00886.x","volume":"99","author":"Y Hirai","year":"2008","unstructured":"Hirai Y, Banno K, Suzuki M et al (2008) Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. Cancer Sci 99:1715\u20131719","journal-title":"Cancer Sci"},{"key":"1953_CR26","first-page":"479","volume":"9","author":"T Takeda","year":"2018","unstructured":"Takeda T, Banno K, Yanokura M et al (2018) Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: a case report. Mol Clin Oncol 9:479\u2013484","journal-title":"Mol Clin Oncol"},{"key":"1953_CR27","first-page":"20","volume":"7","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR et al (2013)\u00a0Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 7:20","journal-title":"Curr Protoc Hum Genet"},{"key":"1953_CR28","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/jcp.2005.031757","volume":"59","author":"M Nielsen","year":"2006","unstructured":"Nielsen M, Poley JW, Verhoef S et al (2006) Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol 59:1212\u20131215","journal-title":"J Clin Pathol"},{"key":"1953_CR29","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1200\/JCO.2008.21.6853","volume":"27","author":"SJ Lubbe","year":"2009","unstructured":"Lubbe SJ, Di Bernardo MC, Chandler IP et al (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27:3975\u20133980","journal-title":"J Clin Oncol"},{"issue":"1976\u20131985","key":"1953_CR30","first-page":"e1","volume":"137","author":"S Vogt","year":"2009","unstructured":"Vogt S, Jones N, Christian D et al (2009) Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 137(1976\u20131985):e1-10","journal-title":"Gastroenterology"},{"issue":"1208\u20131211","key":"1953_CR31","first-page":"e1","volume":"146","author":"AK Win","year":"2014","unstructured":"Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146(1208\u20131211):e1-5","journal-title":"Gastroenterology"},{"key":"1953_CR32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.cgh.2016.02.020","volume":"14","author":"SJ Walton","year":"2016","unstructured":"Walton SJ, Kallenberg FG, Clark SK et al (2016) Frequency and features of duodenal adenomas in patients with MUTYH-associated polyposis. Clin Gastroenterol Hepatol 14:986\u2013992","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1953_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10689-018-00116-2","volume":"18","author":"EG Sutcliffe","year":"2019","unstructured":"Sutcliffe EG, Bartenbaker Thompson A et al (2019) Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis. Fam Cancer 18:203\u2013209","journal-title":"Fam Cancer"},{"key":"1953_CR34","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/cncr.31534","volume":"124","author":"T Adar","year":"2018","unstructured":"Adar T, Rodgers LH, Shannon KM et al (2018) Unicersal screening of both endometrial and colon cancers increases the detection of Lynch syndrome. Cancer 124:3145\u20133153","journal-title":"Cancer"},{"key":"1953_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2013.04.022","volume":"130","author":"J Moline","year":"2013","unstructured":"Moline J, Mahdi H, Yang B et al (2013) Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical cancer. Gynecol Oncol 130:121\u2013126","journal-title":"Gynecol Oncol"},{"key":"1953_CR36","doi-asserted-by":"publisher","first-page":"e79737","DOI":"10.1371\/journal.pone.0079737","volume":"8","author":"C Egoavil","year":"2013","unstructured":"Egoavil C, Alenda C, Castillejo A et al (2013) Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. PLoS ONE 8:e79737","journal-title":"PLoS ONE"},{"key":"1953_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pathol.2017.05.004","volume":"49","author":"F Najdawi","year":"2017","unstructured":"Najdawi F, Crook A, Maidens J et al (2017) Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Pathology 49:457\u2013464","journal-title":"Pathology"},{"key":"1953_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ygyno.2017.08.016","volume":"147","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Sato N, Sugawara T et al (2017) Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer. Gynecol Oncol 147:388\u2013395","journal-title":"Gynecol Oncol"},{"key":"1953_CR39","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1200\/JCO.2003.04.094","volume":"21","author":"MJ Berends","year":"2003","unstructured":"Berends MJ, Wu Y, Sijmons RH et al (2003) Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21:4364\u20134370","journal-title":"J Clin Oncol"},{"key":"1953_CR40","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","volume":"25","author":"KH Lu","year":"2007","unstructured":"Lu KH, Schorge JO, Rodabaugh KJ et al (2007) Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J Clin Oncol 25:5158\u20135164","journal-title":"J Clin Oncol"},{"key":"1953_CR41","first-page":"37","volume":"36","author":"RO Taha","year":"2019","unstructured":"Taha RO, Murat A, Muzaffer S et al (2019) Targeted next-generation sequencing of MLH1, MSH2, and MSH6 genes in patients with endometrial carcinoma under 50 years of age. Balkan Med J 36:37\u201342","journal-title":"Balkan Med J"},{"key":"1953_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/carcin\/bgz046","volume":"40","author":"T Makabe","year":"2019","unstructured":"Makabe T, Arai E, Hirano T et al (2019) Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer. Carcinogenesis 40:611\u2013623","journal-title":"Carcinogenesis"},{"key":"1953_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"K Schmeler","year":"2006","unstructured":"Schmeler K, Lynch H, Chen L et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engle D Med 354:261\u2013269","journal-title":"N Engle D Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-01953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-021-01953-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-021-01953-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T08:19:29Z","timestamp":1629101969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-021-01953-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1007\/s10147-021-01953-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DA reports personal fees from MSD K.K., personal fees from AstraZeneca K.K., personal fees from Chugai Pharmaceutical Co., Ltd., outside the submitted work. The rest of the authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}